ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 항구토제 시장은 2025년부터 2030년까지 19억 1,860만 달러 증가하고, 예측 기간 동안 CAGR은 6.4%로 예측됩니다.
세계의 항구토제 시장에 대해 조사분석했으며, 시장 규모와 예측, 동향, 성장요인, 과제, 약 25개 벤더 분석 등의 정보를 전해드립니다.
본 보고서는 현재 시장 상황, 최신 동향 및 촉진요인, 시장 환경 전반에 대한 최신 분석을 제공합니다. 시장은 암 환자 증가와 화학요법으로 인한 메스꺼움에 대한 수요, 제제 기술 및 전달 시스템의 발전, 멀미 등 비암 영역으로의 확대에 의해 주도되고 있습니다.
본 조사는 업계 주요 관계자들의 정보를 포함한 1차 정보와 2차 정보를 객관적으로 조합하여 실시되었습니다. 이 보고서에는 주요 기업 분석과 함께 종합적인 시장 규모 데이터, 지역별 분석과 함께 부문 및 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 수록되어 있습니다.
시장 범위
기준 연도
2026년
종료 연도
2030년
예측 기간
2026-2030년
성장 모멘텀
가속
전년비 2026년
6.2%
CAGR
6.4%
증가액
19억 1,860만 달러
이번 조사에서는 향후 몇 년간 세계 항구토제 시장 성장을 견인할 주요 요인 중 하나로 속효성 및 지속성 주사제의 채택 확대가 꼽혔습니다. 또한, 제품 포트폴리오 확장을 위한 전략적 제휴 및 인수, 다중 작용 기전에 대한 규제 당국의 장려책은 시장에서 상당한 수요 창출로 이어질 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
제3장 시장 구도
제4장 시장 규모
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 약물 종류별
제9장 시장 세분화 : 용도별
제10장 시장 세분화 : 투여 경로별
제11장 고객 상황
제12장 지역별 상황
제13장 촉진요인, 과제, 기회
제14장 경쟁 구도
제15장 경쟁 분석
제16장 부록
KSM
영문 목차
영문목차
The global antiemetic drug market is forecasted to grow by USD 1918.6 mn during 2025-2030, accelerating at a CAGR of 6.4% during the forecast period. The report on the global antiemetic drug market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cancer and demand for chemotherapy induced nausea, advancements in formulation technologies and delivery systems, expansion into non-oncology indications for motion sickness.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Market Scope
Base Year
2026
End Year
2030
Series Year
2026-2030
Growth Momentum
Accelerate
YOY 2026
6.2%
CAGR
6.4%
Incremental Value
$1918.6 mn
Technavio's global antiemetic drug market is segmented as below:
By Drug Class
5-HT 3 receptor antagonist
Dopamine antagonist
NK 1 receptor antagonist
Cannabinoid receptor antagonist
Others
By Application
Chemotherapy
Surgery
Gastroenteritis
Others
By Route Of Administration
Injectable
Oral
Transdermal
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Russia
Asia
Rest of World (ROW)
Rest of World (ROW)
This study identifies the increasing adoption of ready to use and long-acting injectable formulations as one of the prime reasons driving the global antiemetic drug market growth during the next few years. Also, strategic partnerships and acquisitions to expand portfolios and regulatory encouragement for multi mechanism will lead to sizable demand in the market.
The report on the global antiemetic drug market covers the following areas:
Global antiemetic drug market sizing
Global antiemetic drug market forecast
Global antiemetic drug market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global antiemetic drug market vendors that include Acacia Pharma Group Plc, Accord Healthcare Ltd., Astellas Pharma Inc., B.Braun SE, Baxter International Inc., Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius Kabi AG, GlaxoSmithKline Plc, Helsinn Healthcare SA, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sandoz Group AG, Sanofi SA, Sun Pharmaceutical Industries, Takeda Pharmaceutical Ltd., Teva Pharmaceutical Ltd., Viatris Inc.. Also, the global antiemetic drug market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges
3 Market Landscape
3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
5.1 Global Antiemetic Drug Market 2020 - 2024
Historic Market Size - Data Table on Global Antiemetic Drug Market 2020 - 2024 ($ million)
5.2 Drug Class segment analysis 2020 - 2024
Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
